The Chinese government has always advocated Chinese medicine “going out of the country and going to the world”, and a large number of outstanding enterprises such as Tong Ren Tang and Tasly have emerged in the industry. They set up chain stores and image stores overseas, and brought a new type of marketing model to Chinese herbal health products. all around the world. At the same time, we have also seen that the standards of various countries for the import of Chinese medicine products are gradually increasing, and some countries have introduced special laws and regulations. Therefore, if we want Chinese medicine to truly move toward the world, it is inevitable to increase industry concentration, achieve economies of scale, and strictly control quality. With the continuous advancement of new medical reforms in China and mergers and acquisitions among enterprises, we will expand and strengthen our products. Upgrading product quality and building a strong brand will be the theme of the development of the Chinese medicine industry in the future.

With the continuous increase in demand for green products in the international market, Chinese herbal product exports will continue to grow in 2011, and the dominant products will be mainly concentrated on plant extracts, Chinese herbal medicines, and health products. Foreign traders importing directly into the cultivation base of Chinese herbal medicines will also become increasingly standard and prevalent. This mode of reducing the purchase and sale of intermediate links will help increase labor costs and increase profitability. While the international market continues to maintain strong demand for Chinese herbal medicine products, we should also see that the introduction of the US cGMP ordinance, the implementation of the electronic database verification and management of the import of Korean herbal medicines, and the implementation of the European Union's “Regulations on Traditional Plant Drug Registration Procedures” are all The "examination paper" placed before Chinese medicine companies in China is an important issue that needs to be resolved in the Chinese medicine industry in 2011 and in the future.